The leading source for credible citizen reporting

Help | Login | Join Allvoices

Mainstream News

This event is older than two months and is no longer active. Some links older than two months could be broken.

Click here to post a new related report

Novartis drug combo cuts pancreatic tumour size

Source: International Business Times

Oxford : United Kingdom | 4 months ago

0 0

Afinitor is one of Novartis's most important new drugs and is being tested for use against several different types of cancer, which could help it achieve sales of more than $1 billion annually. It works by blocking a protein known as mTOR and disrupting the growth, division and metabolism of cancer cells...

Share:
Credibility

Tags: cancerous drugs, cancerous cells

More News From: Oxford : United Kingdom

News Stories

NBC Washington: Little Pill Offers New Hope in Breast Cancer Battle

News Source: Androscoggin News | 4 months ago

These were very difficult to treat patients in the past, and now, I have an option besides standard chemotherapy,” she said. Osborne said unlike chemotherapy, the pills target only the cancerous cells and leave the healthy ones unharmed. And while...
CBS 3 Philly (KYW): PARP Inhibitors May Ease Side Effects Of Chemo

News Source: Uinta County News | 4 months ago

Researchers in Britain say they may have found the "Holy Grail" of cancer research. Dr. Holly Phillips stopped by The Early Show to explains how it works...What makes them different from traditional chemotherapy drugs is that they are able to target...
NBC 11 Lubbock (KCBD): New cancer drug shows promising results

News Source: Uinta County News | 4 months ago

This small study of just 60-patients could be one of the most important cancer treatment breakthroughs in a decade...Patients are reporting none of the typical side effects we see with chemo now. That means there is no nausea, no vomiting and no hair...
Novartis drug combo cuts pancreatic tumour size

News Source: International Business Times | 4 months ago

Afinitor is one of Novartis's most important new drugs and is being tested for use against several different types of cancer, which could help it achieve sales of more than $1 billion annually. It works by blocking a protein known as mTOR and...